This dataset represents a group of paper records (a "series") within the Marie C. McCormick papers, 1956-2016 (inclusive), 1968-2009 (bulk), which can be accessed on-site at the Center for the History of Medicine at the Francis A. Countway Library of Medicine in Boston, Massachusetts. The series consists of research administrative and regulatory records, research data, publishing records, and correspondence, generated and compiled by Marie C. McCormick during her tenure as Principal Investigator for Phase IV of the Infant Health and Development Program. Phase IV of the program revisited low-birthweight subjects at 18 years of age (between 2001 and 2004), some of whom had participated in early childhood educational intervention as part of the study. Research during this phase addressed the health, social functioning, mental health, and mental ability of young adult subjects and their siblings; subjects’ family composition, environment, and socio-economic background; and the parenting philosophies and practices of parents or caregivers. More IHDP records may be found in the “Infant Health and Development Program, Phases I-III Records, 1984-2002” and “Infant Health and Development Program, Phase IV Paper Records, 1990-2009” datasets. More publishing records may be found in the “Writings and Publications, 1971-2013 dataverse”. Research administrative records include: Institutional Review Board (IRB) safety plans, confidentiality certificates, and consent forms drafted for various participant categories; site directors’ meeting minutes and agendas; financial and grant funding records; reports; presentations; and administrative correspondence. Research regulatory records consist of: survey instruments and interview schedules; codebooks; and protocols and methodologies. Research data include: coded and analyzed databases and datasets (SAS, SPSS, Microsoft Access, comma-separated value files, tab-delimited files, and spreadsheets); and summarized and analyzed data tables and graphs. Publishing records include manuscript drafts, bibliographies, and correspondence for publications related to IHDP research findings from multiple phases of the program. Correspondence consists of emails and attachments received by McCormick during Phase IV, concerning: research administration (such as research protocols, policies, IRB approval, and grant funding); publishing; and research data results. Email attachments include: manuscript drafts and publishing correspondence; grant funding records; IRB records; and SPSS dataset files. Topics in the subseries include: behavior; academic performance; physical health; nutrition and eating habits; peer and family relationships; household composition and environment; substance abuse and suicidal thoughts; criminal activity; safety and danger; and maternal parenting philosophy and involvement in child’s education and social activities, among other topics. Series also includes collected publications related to the focuses of IHDP research. Data and associated records are accessible onsite at the Center for the History of Medicine per the conditions governing access described below. Conditions Governing Access to Original Collection Materials: The series represented by this dataset includes longitudinal patient information that is restricted for 80 years from the most recently dated records in the “Infant Health and Development Program, Phase IV Paper Records, 1990-2009” series, personnel information that is restricted for 80 years from the date of record creation, and Harvard University and Children’s Hospital Boston institutional records that are restricted for 50 years from the date of record creation. Access to electronic records is also premised on the availability of a computer station, requisite software, and/or the ability of Public Services staff to review and/or print out records of interest in advance of an on-site visit. Researchers should contact Public Services for more information. The Marie C. McCormick papers were processed with grant funding from the Andrew W. Mellon Foundation, as awarded and administered by the Council on Library and Information Resources (CLIR) in 2016. View the Marie C. McCormick Papers finding aid for a full collection inventory of both paper and digital records, and for more information about accessing and using the collection.

28 November 2019. Following an investigation into the GP locum data within this collection, we revised the full-time equivalent (FTE) GP locum figures from September 2015 to December 2016 in the General Practice Workforce September 2019 publication. This follows updates made to the figures from September 2015 to December 2018 as a result of several revisions we made to our data processing and methodology following consultation with users and stakeholders. December 2017, September 2018 and December 2018 figures were published in the first installment of this publication on 21 February, and in a planned revision of the publication, the remaining historical figures from September 2015 to December 2018 were published 25 April. The figures produced under this new methodology were not comparable with any previously published figures, and the GP locum FTE figures in this publication are no longer valid as they have now been superseded by the revised figures. More information and the revised figures can be found on the General Practice Workforce September 2019 publication page at https://digital.nhs.uk/data-and-information/publications/statistical/general-and-personal-medical-services/final-30-september-2019. This quarterly report presents data about GPs, Nurses, Direct Patient Care and Admin/Non-Clinical staff working in General Practice in England, along with information on their patients, practice and the services they provide. Various data breakdowns are available in the accompanying Excel and CSV files, including time series and breakdowns by categories such as age and gender. Data is also presented regionally, and at practice level for December 2018, in the accompanying CSVs. Links to other publications presenting healthcare workforce information can be found under Related Links. On 22.02.2019 some figures in tables 6a and 6b (for each staff group) were updated to align with the latest regional hierarchies.

Essure: database of biomedical studies - New versions of this database will be uploaded in the future. - History of changes will be available in this figshare article. - Version 1. September 16, 2014.Original data values downloaded from ClinicalTrials.gov and PubMed - Google Drive Spreadsheet is open (worldwide) & comments are also allowed (1st URL).

- This archive is open, transparent, and complies with terms of service of websites in which data were originally downloaded. In addition, verification of future analysis posted in this figshare article could be done by anyone because these data was collected from publicly available databases.

Dec 29, 2014 - Update 1. Evidence does not support Bayer statements:The use of Essure as a safe contraceptive method in women is highly questionable. 2. Bayer is withholding Essure safety data. 3. Agencies from several countries (e.g., FDA and INVIMA) acted as facilitators (not regulators): their actions accelerated the entry of Essure into the market. 4. Regulators are also withholding information involving the market approval of Essure. 5. Let's be straight up about the Essure case -- no need to be over-polite here --This discussion is about pharmaceutical crimes committed against thousands of women. These criminal actions were only possible by the complicities of others (e.g., drug regulators and author's of hidden clinical studies). - I have evidence to support the above statements. - Thousands of women have reported serious adverse events after receiving the Essure placement procedure. - Bayer responses to these women are disrespectful, offensive, and shameful. I am here to say that these women are real cases of serious adverse events associated with Essure: - More than one paper will be submitted to peer-review medical journals. - More than one post about Essure will be published in this blog (additional to journal articles). - This is evidence of misleading advertising:http://gilmedica.com/nuestros-productos/quirurgica/pelvis-femenina-2/essure/ Notes:- Please take a look to other types of medical devices advertised by the company promoting the use of Essure in Colombia.-The geographical location of Gilmedica is very close to my home.

The Registry of Vital Records and Statistics collects and produces statistical data about births, deaths and other vital events in the Commonwealth.